Archive for November, 2006

Pfizer to Cut 20% of US Sales Force - Smartmoney.com

Earthtimes.orgPfizer to Cut 20% of US Sales ForceSmartmoney.com - 17 hours ago… under increased pressure due to the loss of patent protection for some of its leading revenue drivers, including antidepressant Zoloft and antibiotic Zithromax … Pfizer Slashes US Sales Force by 20% AdAge.com (subscription)all 253 news articles

Read full story

Comments

Prescription for profits: Hand out pink slips - Marketplace

MarketplacePrescription for profits: Hand out pink slipsMarketplace, CA - 11 hours ago… Part of Pfizer's problems come from losing patents on a couple of its big sellers, antibiotic Zithromax and antidepressant Zoloft. …

Read full story

Comments

Teva Announces Tentative Approval of Sumatriptan Succinate Tablets - PharmaLive.com (press release)

Teva Announces Tentative Approval of Sumatriptan Succinate TabletsPharmaLive.com (press release), PA - 22 hours ago… prior to a final resolution of outstanding litigation, including that relating to the generic versions of Allegra(R), Neurontin(R) and Zithromax(R), the … Teva Announces Tentative Approval of Sumatriptan Succinate Tablets Business Wire (press release)all 20 news articles

Read full story

Comments

Pfizer: Strong Medicine on Costs - BusinessWeek

Earthtimes.orgPfizer: Strong Medicine on CostsBusinessWeek - 7 hours ago… Several of Pfizer's best-performing drugs, including the antidepressant Zoloft, antibacterial treatment Zithromax, and Neurontin for epilepsy, have already … Pfizer Slashes US Sales Force by 20% AdAge.com (subscription)Pfizer to Cut 20% of US Sales Force Smartmoney.comall 231 news articles

Read full story

Comments

Pfizer's Sales Force to be Cut - The Money Times

The Money TimesPfizer's Sales Force to be CutThe Money Times, India - 5 hours ago… Pfizer’s products include antidepressant Zoloft, antibiotic Zithromax, cholesterol-lowering drug Lipitor, pain reliever Celebrex, smoking-cessation product …

Read full story

Comments

Teva Announces Tentative Approval of Sumatriptan Succinate Tablets - Business Wire (press release)

Teva Announces Tentative Approval of Sumatriptan Succinate TabletsBusiness Wire (press release), CA - 2 hours ago… to a final resolution of outstanding litigation, including that relating to the generic versions of Allegra ® , Neurontin ® and Zithromax ® , the effects of … Teva Announces Tentative Approval of Sumatriptan Succinate Tablets Genetic Engineering News (press release)all 3 news articles

Read full story

Comments

Wal*Mart Launches Cheap Generic Drug Program - Fox 21

Wal*Mart Launches Cheap Generic Drug ProgramFox 21, CO - 3 hours ago… cancer. The list includes 14 of the top 20 prescribed medications in the United States, including Lipitor, Amoxicillan, and Zithromax.

Read full story

Comments

Teva and Pfizer Make Up - Motley Fool

Teva and Pfizer Make UpMotley Fool - 4 hours ago… An agreement between the two companies settles patent litigation Pfizer had initiated over a cancer treatment and the antibiotic Zithromax, which Teva had been …

Read full story

Comments

Pfizer Tries to Sell Research Spending - Wall Street Journal (subscription)

Pfizer Tries to Sell Research SpendingWall Street Journal (subscription), NY - 6 hours ago… new chief executive, Jeffrey Kindler, grapple with a slew of patent expirations on some of its best-selling drugs, including the antibiotic Zithromax and the …

Read full story

Comments

Pfizer Patent Dispute Settled - Hartford Courant

Pfizer Patent Dispute SettledHartford Courant, United States - Nov 22, 2006has reached an agreement with Teva Pharmaceutical Industries Ltd. to end patent litigation involving the cancer drug Idamycin and the antibiotic Zithromax. …

Read full story

Comments

· « Previous entries